Sign in to view content

Association of Ultra-Widefield Fluorescein Angiography-identified Retinal Nonperfusion With Risk of Diabetic Retinopathy Worsening Over Time

Paolo Antonio S. Silva, MD

Video
Published 2022

Related

48-Week End of Study Results From BEHOLD Phase 2 Study of UBX1325 in Patients With DME
Arshad M. Khanani, MD, MA, FASRS
Annual Meeting Talks
2023
Do scheduling issues impact commonly needed testing for patients with moderate diabetic retinopathy with macular edema?
Leonard H. Ginsburg, MD
On Demand Cases, Courses, and Papers
2019
Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema
Victor Hugo Gonzalez, MD
Updates from the Field
2024

Category: Diabetic Retinopathy

See more